IrisVision’s beginnings stretch back to 2014. Co-founder Frank Werblin, PhD, a Guggenheim Fellow and UC Berkeley professor of neuroscience for more than 40 years, had discovered a number of cellular associations underlying visual information processing in the retina. His work on retinal chip implants to help the blind see led him to a solution that was less invasive and more affordable: a tool accessible for the wider low-vision community.
We are on a mission to help even the most challenged and at-risk patients. Our goal is to preserve and make the most of their sight by forging new frontiers for the delivery of care at the intersection of digital health and vision science.